Jounce stock price
NettetJounce Therapeutics Inc (JNCE) Stock Price Today, News, Quotes, FAQs and Fundamentals More Advertisement 3rd Party Ad. Not an offer or recommendation by … NettetJNCE: Get the latest Jounce Therapeutics stock price and detailed information including JNCE news, ... According to the current price, Jounce Therapeutics is 23.05% away from the 52-week high.
Jounce stock price
Did you know?
Nettet4. apr. 2024 · JOUNCE THERAPEUTICS, INC. : JNCE Stock Price US4811161011 MarketScreener Homepage Equities United States Nasdaq Jounce Therapeutics, Inc. … Nettet10. apr. 2024 · Jounce Therapeutics NasdaqGS:JNCE Stock Report Last Price US$1.85 Market Cap US$96.8m 7D 22.5% 1Y -74.1% Updated 02 Apr, 2024 Data Company …
NettetJounce Therapeutics (JNCE) is set to be acquired by Concentra Biosciences, spurning an all-share merger deal with British biotech firm Redx Pharma. CRSP : 45.40 (+1.34%) JNCE : 1.8900 (-0.53%) CERT : 23.01 (+0.52%) EQRX : 1.8900 (+2.72%) SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, USX, JNCE … Nettet31. mar. 2024 · March 14, 2024. 9:00 pm ET. Jounce Therapeutics Confirms Receipt of Unsolicited Proposal from Concentra Biosciences. Globe Newswire. March 13, 2024. 7:00 am ET. Jounce Therapeutics stock bounces after saying only 1.4% of its cash was in an SVB operating account. MarketWatch. March 09, 2024.
Nettet13. apr. 2024 · Jounce Therapeutics Inc. (NASDAQ:JNCE) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 1.07% to the previous day’s close as strong demand from buyers drove the stock to $1.89. Actively observing the price movement in the last trading, the stock closed the session at $1.87, falling within a … NettetJounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights March 27, 2024TipRanks. …
Nettet31. mar. 2024 · nasdaq.com - October 17 at 3:31 PM. Jounce Therapeutics to Participate in the Upcoming Investor Conferences. finance.yahoo.com - September 7 at 9:45 AM. Jounce (JNCE) SELECT Study Fails to Meet Goal, Stock Down. nasdaq.com - August 31 at 12:04 PM. Jounce Therapeutics Shares Fall After Disappointing Mid-Stage Lung …
Nettet27. mar. 2024 · JOUNCE THERAPEUTICS, INC. (Name of Person (s) Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 481116101 (CUSIP Number of Common Stock) Jacquelyn... hiksolutionNettet14. apr. 2024 · Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, Jounce Therapeutics presently has an average rating of "Hold" and a consensus target price of $6.00. Jounce Therapeutics Price Performance. Shares of NASDAQ:JNCE opened at … hiksaiNettet7. mar. 2024 · Jounce Therapeutics Inc. (NASDAQ:JNCE) traded at $1.06 at last check on Tuesday, March 07, made a downward move of -1.85% on its previous day’s price. Looking at the stock we see that its previous close was $1.08 and the beta (5Y monthly) reads 0.65 with the day’s price range being $1.01 hiksa porcelainNettet5. apr. 2024 · Jounce Therapeutics (JNCE) Stock Price & Analysis 302 Followers JNCE Stock Chart & Stats Advanced Chart > Day’s Range $0 - $0 52-Week Range $0.58 - $7.94 Previous Close $1.85 Volume 5.37M Average Volume (3M) 2.75M Market Cap $96.46M Enterprise Value $96.46M Total Cash (Recent Filing) $0.00 Total Debt (Recent Filing) … hikuazn settingsNettet18. apr. 2024 · According to our current JNCE stock forecast, the value of Jounce Therapeutics, Inc. shares will rise by 5.41%and reach $ 3.68 per share by September 14, 2024. According to our technical indicators, the current sentiment is Bearishwhile the Fear & Greed Index is showing 39 (Fear). hiks hitta kliniska studierNettetJNCE: Get the latest Jounce Therapeutics stock price and detailed information including JNCE news, ... According to the current price, Jounce Therapeutics is 23.05% away … hiksionNettet29. des. 2024 · Jounce’s cash position at the end of September 2024 was $130.3 million compared to $220.2 million as of December 31, 2024. That means its cash burn is quite high, with approximately $120 million... hikuillui